4.7 Article

Structural and energetic insights into the selective inhibition of PKMYT1 against WEE1

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Chemistry, Medicinal

Structural Understanding of Peptide-Bound G Protein-Coupled Receptors: Peptide-Target Interactions

Yuxin Shi et al.

Summary: This article summarizes the known structural complexes of G protein-coupled receptors (GPCRs) bound to peptide ligands, with a focus on the interactions between the receptor and its peptide ligand at the orthosteric site. In-depth structural investigations have provided valuable insights into the molecular mechanisms underlying peptide recognition, contributing to the discovery of GPCR peptide drugs with improved therapeutic effects.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

Computational simulation studies on the binding selectivity of Wee1 and Checkpoint kinase 1 by molecular dynamics simulation combined with free energy calculations

Yaping Li et al.

Summary: This study analyzed the selective mechanisms of Wee1 and Chk1 through molecular docking, molecular dynamics simulations, and binding free energy calculations. The results indicated that key residues play a crucial role in the binding interactions between ligands and receptors, providing a better understanding of the selective mechanism of Wee1 and Chk1.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)

Article Oncology

PKMYT1 regulates the proliferation and epithelial-mesenchymal transition of oral squamous cell carcinoma cells by targeting CCNA2

Ye Cai et al.

Summary: This study revealed that PKMYT1 is highly expressed in oral squamous cell carcinoma (OSCC) and knocking down PKMYT1 can inhibit cell proliferation, migration, and epithelial-mesenchymal transition (EMT). PKMYT1 was found to bind to CCNA2 and regulate its expression. Therefore, PKMYT1 may serve as a potential target for improving OSCC treatment in the future.

ONCOLOGY LETTERS (2022)

Article Biochemistry & Molecular Biology

Delineating the activation mechanism and conformational landscape of a class B G protein-coupled receptor glucagon receptor

Ying Wang et al.

Summary: This study investigates the activation mechanism of a class B GPCR, human glucagon receptor-GCGR, using molecular dynamics simulations and Markov state models. The study reveals the conformational dynamics and activation process of GCGR and highlights the role of Gs in stabilizing the glucagon binding site and achieving full activation of the receptor.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2022)

Article Multidisciplinary Sciences

CCNE1 amplification is synthetic lethal with PKMYT1 kinase inhibition

David Gallo et al.

Summary: Amplification of the CCNE1 locus on chromosome 19q12 is common in various tumor types, especially in high-grade serous ovarian cancer, uterine tumors, and gastro-esophageal cancers. The amplification of CCNE1 is associated with genome instability, high levels of cyclin E, and resistance to cytotoxic and targeted therapies. Through genome-scale CRISPR-Cas9-based synthetic lethality screens, it was discovered that increasing CCNE1 dosage creates vulnerability to the inhibition of the PKMYT1 kinase, a negative regulator of CDK1. Inhibiting PKMYT1 through the development of RP-6306, an orally available and selective inhibitor, shows single-agent activity and durable tumor regressions when combined with gemcitabine in models of CCNE1 amplification. This treatment activates CDK1 selectively in CCNE1-overexpressing cells, promoting early mitosis in cells undergoing DNA synthesis, which is disrupted by CCNE1 overexpression. Thus, PKMYT1 inhibition is a promising therapeutic strategy for CCNE1-amplified cancers.

NATURE (2022)

Article Chemistry, Medicinal

Discovery of an Orally Bioavailable and Selective PKMYT1 Inhibitor, RP-6306

Janek Szychowski et al.

Summary: PKMYT1 acts as a regulator of CDK1 phosphorylation and has been identified as a potential therapeutic target for certain types of DNA damage response cancers. In this study, a weak inhibitor of PKMYT1 was identified and further optimized using structure-based drug design to improve its potency. The resulting potent and selective inhibitors, such as RP 6306, showed inhibitory effects on CCNE1-amplified tumor cell growth in preclinical xenograft models. RP 6306 is currently being evaluated in Phase 1 clinical trials for the treatment of various solid tumors.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Mechanistic Insights into the Long-range Allosteric Regulation of KRAS Via Neurofibromatosis Type 1 (NF1) Scaffold Upon SPRED1 Loading

Minyu Li et al.

Summary: Allosteric regulation plays a crucial role in protein function, but understanding long-range allosteric regulation remains challenging. This study investigates the allosteric regulation of KRAS by SPRED1, providing mechanistic insights and shedding light on long-range allosteric regulation in complex macromolecular systems.

JOURNAL OF MOLECULAR BIOLOGY (2022)

Article Biochemistry & Molecular Biology

Insights into the Allosteric Effect of SENP1 Q597A Mutation on the Hydrolytic Reaction of SUMO1 via an Integrated Computational Study

Mingfei Ji et al.

Summary: This study elucidated the effects of the SENP1 Q597A mutation on conformation, catalytic activity, and binding affinity of the SENP1-SUMO1 complex using molecular dynamics simulations and binding free energy calculations.

MOLECULES (2022)

Article Biochemistry & Molecular Biology

Mechanistic Insights into the Mechanism of Inhibitor Selectivity toward the Dark Kinase STK17B against Its High Homology STK17A

Chang Liu et al.

Summary: This study investigates the molecular mechanism of the binding selectivity of PKIS43 towards STK17B. The findings suggest that the difference in protein-ligand electrostatic interactions and the energy contribution from Arg41 in the phosphate-binding loop of STK17B are crucial for the binding specificity of PKIS43.

MOLECULES (2022)

Article Chemistry, Medicinal

Markov State Models and Molecular Dynamics Simulations Reveal the Conformational Transition of the Intrinsically Disordered Hypervariable Region of K-Ras4B to the Ordered Conformation

Hao Zhang et al.

Summary: This study reveals the transition pathway of the C-terminal hypervariable region (HVR) of K-Ras4B, identifies key conformational substates, and uncovers important interactions between the HVR and the catalytic domain. These findings are essential for a deeper understanding of the HVR transition mechanism and the regulation of K-Ras4B activity.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2022)

Article Biochemistry & Molecular Biology

Elucidation of the conformational dynamics and assembly of Argonaute-RNA complexes by distinct yet coordinated actions of the supplementary microRNA

Haiming Zhuang et al.

Summary: This study reveals that additional supplementary pairing can enhance the interaction between miRNA and target RNA, and influence the conformational dynamics and assembly of AGO protein. These findings provide guidance for the design of miRNA mimics and anti-miRNAs, and open up new possibilities for engineering AGO proteins in the field of gene regulation.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2022)

Article Pharmacology & Pharmacy

Mechanism of allosteric activation of SIRT6 revealed by the action of rationally designed activators

Shaoyong Lu et al.

Summary: The discovery of activator compounds binding to an allosteric site on SIRT6 has potential implications for aging-related and cancer diseases. The mechanism of allosteric activation by MDL-801 involves conformational rotation of the substituent on the R-ring, leading to increased deacetylation activity. The presence of the 5-Br atom in MDL-801 may serve as an allosteric driver controlling the ligand's effectiveness.

ACTA PHARMACEUTICA SINICA B (2021)

Article Biochemistry & Molecular Biology

LncRNA PKMYT1AR promotes cancer stem cell maintenance in non-small cell lung cancer via activating Wnt signaling pathway

Yaomei He et al.

Summary: In this study, a human-specific long non-coding RNA (lncRNA, ENST00000595422) named PKMYT1AR was identified as induced in NSCLC, especially in cancerous cell lines, and its high expression correlated with worse clinical outcomes. Knockdown of PKMYT1AR inhibited tumor cell proliferation, migration, and formation abilities. PKMYT1AR was shown to directly interact with miR-485-5p to attenuate its inhibitory role on the downstream oncogenic factor PKMYT1 in NSCLC. Furthermore, the miR-485-5p was downregulated in both cancerous cell lines and serum from NSCLC patients, and its forced expression inhibited tumor cell proliferation and migration abilities.

MOLECULAR CANCER (2021)

Article Chemistry, Medicinal

Development of a Pantetheine Force Field Library for Molecular Modeling

Shiji Zhao et al.

Summary: The development of the Pantetheine Force Field (PFF) library allows for the modeling of systems containing PCLs in silico, supporting various applications including protein engineering and drug discovery. Validation studies have shown promising performance in molecular dynamics simulations compared to experimental data of representative systems.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2021)

Article Biochemistry & Molecular Biology

Conformational Selection Mechanism Provides Structural Insights into the Optimization of APC-Asef Inhibitors

Xinheng He et al.

Summary: This study utilized molecular dynamics simulations and analyses to uncover the inhibition mechanism of APC-Asef, providing insights for further optimization.

MOLECULES (2021)

Article Oncology

Safety, Antitumor Activity, and Biomarker Analysis in a Phase I Trial of the Once-daily Wee1 Inhibitor Adavosertib (AZD1775) in Patients with Advanced Solid Tumors

Naoko Takebe et al.

Summary: This study identified the recommended phase II dose of once-daily adavosertib and observed activity in patients with ovarian or endometrial carcinoma. Some patients exhibited baseline CCNE1 mRNA overexpression, which may be associated with response.

CLINICAL CANCER RESEARCH (2021)

Article Chemistry, Medicinal

Discovery of ZN-c3, a Highly Potent and Selective Wee1 Inhibitor Undergoing Evaluation in Clinical Trials for the Treatment of Cancer

Peter Q. Huang et al.

Summary: Wee1 inhibition has emerged as a promising therapy for cancer treatment in the past decade. Compound 16, a highly selective Wee1 inhibitor with balanced potency and pharmacokinetic properties, has shown excellent in vivo efficacy and is currently in phase 2 clinical trials.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

Markov State Models and Molecular Dynamics Simulations Provide Understanding of the Nucleotide-Dependent Dimerization-Based Activation of LRRK2 ROC Domain

Xinyi Li et al.

Summary: This study reveals the dynamic structural rearrangement of the ROC homodimer during nucleotide turnover and uncovers a nucleotide-dependent dimerization-based activation scheme adopted by ROC GTPase. Furthermore, it provides insight into the potential allosteric molecular mechanism for the pathogenetic effects of PD-relevant mutations within the ROC domain, offering guidance for identifying regulatory allosteric pockets on the ROC complex. The investigations shed light on the thermodynamics and kinetics of ROC homodimer during nucleotide-dependent activation for the first time and offer guidance for exploiting ROC as therapeutic targets in PD treatment.

MOLECULES (2021)

Review Biotechnology & Applied Microbiology

Trends in kinase drug discovery: targets, indications and inhibitor design

Misty M. Attwood et al.

Summary: The article analyzes the landscape of approved and investigational therapies that target kinases, highlighting the increasing importance of kinase inhibitors in oncology and beyond. It discusses trends in kinase inhibitor design and points out that there are still substantial unexplored opportunities for this drug class.

NATURE REVIEWS DRUG DISCOVERY (2021)

Article Multidisciplinary Sciences

Activation pathway of a G protein-coupled receptor uncovers conformational intermediates as targets for allosteric drug design

Shaoyong Lu et al.

Summary: G protein-coupled receptors (GPCRs) are a critical target for drug development, and the comprehensive characterization of the angiotensin II (AngII) type 1 receptor (AT1R) provides insights into designing allosteric GPCR modulators.

NATURE COMMUNICATIONS (2021)

Article Biochemistry & Molecular Biology

Conformational selection of vasopressin upon V1a receptor binding

Kateryna Che et al.

Summary: This study utilized virtual screening strategies and experimental nuclear magnetic resonance data to reveal the conformational selectivity features of VP-V1aR complex formation. The conformation of VP's three-residue tail significantly modulated the complex dissociation constants, with solvent-exposed and more flexible structures binding to the receptor with enhanced affinities. This research provides insights into the evolutionary selected conformational properties of VP and guides the design of more potent and selective VP analogues.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)

Article Biochemistry & Molecular Biology

Atomic-scale insights into allosteric inhibition and evolutional rescue mechanism of Streptococcus thermophilus Cas9 by the anti-CRISPR protein AcrIIA6

Xinyi Li et al.

Summary: CRISPR-Cas systems in prokaryotes serve as adaptive immunity against invading phages and plasmids. Phages have developed diverse protein inhibitors, called anti-CRISPR (Acr) proteins, to counteract this system, leading bacteria to co-evolve Cas variants as anti-anti-CRISPR systems. At the atomic level, interactions between Streptococcus thermophilus Cas9 (St1Cas9) and the anti-CRISPR protein AcrIIA6 alter the conformational dynamics and catalytic activity of St1Cas9, highlighting a potential for designing allosteric Acr peptidomimetics.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)

Article Biochemistry & Molecular Biology

Structural determinants of ligands recognition by the human mitochondrial basic amino acids transporter SLC25A29. Insights from molecular dynamics simulations of the c-state

Andrea Pasquadibisceglie et al.

Summary: SLC25A29 in mitochondria is responsible for the translocation of basic amino acids. Nitric oxide levels from amino acid metabolism can affect cancer cells' metabolic status, while metabolic diseases related to mitochondrial dysregulation can be improved by reducing the activity of SLC25A29. Structural analysis of SLC25A29 has provided insights into ligands recognition and interaction critical for binding and translocation.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)

Article Biochemistry & Molecular Biology

Mechanistic insights into the effect of phosphorylation on Ras conformational dynamics and its interactions with cell signaling proteins

Yuanhao Wang et al.

Summary: The dual phosphorylation of K-Ras induces structural changes affecting nucleotide and catalytic sites, reducing the catalytic competence and signal delivery abilities of GAP, SOS, and Raf. Phosphorylation also disrupts the Ras/Raf interface allosteric pathway, altering the distribution of Ras-GTP sub-states and identifying potential druggable pockets. These findings highlight the impact of phosphorylation on Ras function and signal transduction, suggesting it as a target for cancer drug discovery.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)

Article Biochemistry & Molecular Biology

Insights into the molecular mechanism of positive cooperativity between partial agonist MK-8666 and full allosteric agonist AP8 of hGPR40 by Gaussian accelerated molecular dynamics (GaMD) simulations

Xiaoli An et al.

Summary: This study elucidates the mechanism of conformational coupling between different sites of the protein, highlighting the crucial role of flexibility in certain regions for agonist binding and action. The results provide important structural information for the design of novel GPR40 agonists.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)

Article Biochemistry & Molecular Biology

Direct interaction between ABCA1 and HIV-1 Nef: Molecular modeling and virtual screening for inhibitors

Alexei A. Adzhubei et al.

Summary: HIV-1 infection impairs cellular cholesterol efflux through downregulation of the cholesterol transporter ABCA1, with potential implications for metabolic co-morbidities. Inhibitors targeting the Nef:ABCA1 interaction may offer a promising approach to attenuate HIV-associated co-morbidities.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)

Article Chemistry, Multidisciplinary

Discovery of cryptic allosteric sites using reversed allosteric communication by a combined computational and experimental strategy

Duan Ni et al.

Summary: Allostery is a direct and efficient method for fine-tuning protein functions, gaining recognition in drug discovery. Identifying allosteric sites is a challenge for drug design, with recent studies revealing bidirectional allosteric coupling and reversed communication between orthosteric and allosteric sites. A new framework combining computational and experimental strategies has been proposed for predicting allosteric sites, demonstrating desirable performance in identifying potential cryptic sites for allosteric drug design.

CHEMICAL SCIENCE (2021)

News Item Biotechnology & Applied Microbiology

PKMYT1: a forgotten member of the WEE1 family

Christopher R. M. Asquith et al.

NATURE REVIEWS DRUG DISCOVERY (2020)

Article Biochemistry & Molecular Biology

Insight into the mechanism of allosteric activation of PI3Kα by oncoprotein K-Ras4B

Xinyi Li et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)

Article Chemistry, Medicinal

ProtoCaller: Robust Automation of Binding Free Energy Calculations

Miroslav Suruzhon et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)

Article Genetics & Heredity

PKMYT1 as a Potential Target to Improve the Radiosensitivity of Lung Adenocarcinoma

Huan-ping Long et al.

FRONTIERS IN GENETICS (2020)

Article Chemistry, Medicinal

Molecular Dynamics Reveals a DNA-Induced Dynamic Switch Triggering Activation of CRISPR-Cas12a

Aakash Saha et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)

Article Chemistry, Medicinal

Computer-aided design, synthesis and biological characterization of novel inhibitors for PKMYT1

Abdulkarim Najjar et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Article Chemistry, Physical

Insight into the selective binding mechanism of DNMT1 and DNMT3A inhibitors: a molecular simulation study

Tianli Xie et al.

PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2019)

Article Chemistry, Medicinal

Structural Basis of Wee Kinases Functionality and Inactivation by Diverse Small Molecule Inhibitors

Jin-Yi Zhu et al.

JOURNAL OF MEDICINAL CHEMISTRY (2017)

Article Chemistry, Physical

ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB

James A. Maier et al.

JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2015)

Article Chemistry, Physical

PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data

Daniel R. Roe et al.

JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2013)

Article Oncology

Preclinical Evaluation of the WEE1 Inhibitor MK-1775 as Single-Agent Anticancer Therapy

Amy D. Guertin et al.

MOLECULAR CANCER THERAPEUTICS (2013)

Article Chemistry, Multidisciplinary

An overview of the Amber biomolecular simulation package

Romelia Salomon-Ferrer et al.

WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL MOLECULAR SCIENCE (2013)

Article Chemistry, Multidisciplinary

AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility

Garrett M. Morris et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)

Review Chemistry, Physical

Clustering molecular dynamics trajectories: 1. Characterizing the performance of different clustering algorithms

Jianyin Shao et al.

JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2007)

Article Chemistry, Multidisciplinary

Development and testing of a general amber force field

JM Wang et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)